NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
501 Göteborg |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 83 | 0.3% | 18 | 0.1% | . | . | 4 | 0.0% | . | . | . | . | . | . | 24088 | 99.6% | 24193 | 100.0% |
ASCUS | 513 | 17.5% | 681 | 23.2% | 4 | 0.1% | 335 | 11.4% | 2 | 0.1% | 7 | 0.2% | 13 | 0.4% | 1376 | 46.9% | 2931 | 100.0% |
CIN1 | 89 | 17.2% | 183 | 35.4% | 1 | 0.2% | 115 | 22.2% | . | . | 1 | 0.2% | . | . | 128 | 24.8% | 517 | 100.0% |
Atypical glandular cells/AGC | 2 | 16.7% | 4 | 33.3% | . | . | 1 | 8.3% | 3 | 25.0% | 1 | 8.3% | . | . | 1 | 8.3% | 12 | 100.0% |
Unclear atypia | . | . | . | . | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% | 1 | 100.0% |
ASC-H | 15 | 13.6% | 19 | 17.3% | . | . | 71 | 64.5% | 1 | 0.9% | 1 | 0.9% | . | . | 3 | 2.7% | 110 | 100.0% |
CIN2 | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | 1 | 100.0% |
CIN3 | 18 | 6.2% | 35 | 12.1% | 2 | 0.7% | 200 | 69.0% | 7 | 2.4% | 11 | 3.8% | 1 | 0.3% | 16 | 5.5% | 290 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | 2 | 50.0% | 1 | 25.0% | 1 | 25.0% | . | . | . | . | 4 | 100.0% |
Total | 720 | 2.6% | 940 | 3.4% | 7 | 0.0% | 729 | 2.6% | 14 | 0.0% | 22 | 0.1% | 14 | 0.0% | 25613 | 91.3% | 28059 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81403 |